Linz, P. E., Lovato, L. C., Byington, R. P., O’Connor, P. J., Leiter, L. A., Weiss, D., . . . Elam, M. B. (2014). Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial. American Diabetes Association.
Stile di citazione ChicagoLinz, Peter E., et al. Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial. American Diabetes Association, 2014.
Citazione MLALinz, Peter E., et al. Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial. American Diabetes Association, 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.